Przydatność preparatu Renobion® w terapii bólu pooperacyjnego u psów i kotów

Piśmiennictwo

Aviram J., Lewitus G.M., Vysotski Y., Uribayev A., Procaccia S., Cohen I., Leibovici A., Abo-Amna M., Akria L., Goncharov D., Mativ N., Kauffman A., Shai A., Hazan O., Bar-Sela G., Meiri D.: Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients. „Pharmaceuticals (Basel)”, 2020, 30, 435.

Backes M.: Marihuana i medycyna. Praktyczny przewodnik po świecie medycznej marihuany. Wydawnictwo Purana, 2015.

Bar-Sela G.,  Zalman D., Valerya Semenysty V., Ballan E.: The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. „Integr Cancer Ther”, 2019, 18, 153.

Blake A., Wan B.A.: A selective review of medical cannabis in cancer pain management. „Ann Palliat Med”, 2017, 6, 215-222.

Booz G.W.: Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. „Free Radic Biol Med”, 2011, 51 (5), 1054-1056.

Bostwick J.M.: Blurred boundaries: the therapeutics and politics of medical marijuana. „Mayo Clin Proc”, 2012, 87 (2), 172-186.

Brioschi F.A.,  Di Cesare F.: Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis. „Animals (Basel)”, 2020, 26, 10.

Deabold K.A., Wayne S., Schwark W.S., Wolf L.: Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats. „Animals (Basel)”, 2019, 19, 832.

Della Rocca G., Di Salvo A.: Hemp in Veterinary Medicine: From Feed to Drug. „Front Vet Sci”, 2020, 7, 387.

Devinsky O., Cilio M.R., Cross H., Fernandez-Ruiz J., French J., Hill C., Katz R., Di Marzo V., Jutras-Aswad D., Notcutt W.G., Martinez-Orgado J., Robson P.J., Rohrback B.G., Thiele E., Whalley B., Friedman D.: Cannabidiol: pharmacology and potential the...